According to SEC filings for the period ending December 2025, Esperion Therapeutics, Inc. (NASDAQ:ESPR) is held by 46 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30 Sep, 2025 | 14,833,791 | 120,726 | 0.82% | $39,309,546.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 12,092,449 | 375,620 | 3.21% | $32,044,990.00 |
| Two Seas Capital LP | 30 Sep, 2025 | 9,749,724 | -205,251 | -2.06% | $25,836,769.00 |
| WASATCH ADVISORS LP | 30 Sep, 2025 | 7,061,857 | -3,278,404 | -31.71% | $18,713,921.00 |
| PenderFund Capital Management Ltd. | 30 Sep, 2025 | 6,676,519 | 0 | 0.00% | $17,692,775.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 4,751,396 | 167,408 | 3.65% | $12,593,578.00 |
| STATE STREET CORP | 30 Sep, 2025 | 4,478,834 | 720,112 | 19.16% | $11,868,910.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 4,055,626 | 3,000,139 | 284.24% | $10,747,409.00 |
| Nuveen, LLC | 30 Sep, 2025 | 3,711,069 | 3,288,456 | 778.12% | $9,834,333.00 |
| AIGH Capital Management LLC | 30 Sep, 2025 | 3,000,000 | 3,000,000 | 0.00% | $7,950,000.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 2,521,439 | -2,790,813 | -52.54% | $6,681,814.00 |
| ROYCE & ASSOCIATES LP | 30 Sep, 2025 | 2,293,488 | 2,293,488 | 0.00% | $6,077,743.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 2,238,618 | 410,624 | 22.46% | $5,932,338.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 2,115,058 | 1,468,883 | 227.32% | $5,604,904.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 1,908,000 | -185,700 | -8.87% | $5,056,200.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 1,848,437 | 64,311 | 3.60% | $4,898,358.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 1,708,807 | 910,053 | 113.93% | $4,528,339.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 1,530,364 | 1,530,364 | 0.00% | $4,055,465.00 |
| Integral Health Asset Management, LLC | 30 Sep, 2025 | 1,500,000 | 1,500,000 | 0.00% | $3,975,000.00 |
| UBS Group AG | 30 Sep, 2025 | 1,246,310 | -290,902 | -18.92% | $3,302,722.00 |